- Home
- APRE vs LUCY Comparison
APRE vs LUCY Comparison
Compare APRE & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- LUCY
- Stock Information
- Founded
- APRE 2006
- LUCY 2017
- Country
- APRE United States
- LUCY United States
- Employees
- APRE N/A
- LUCY N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- LUCY Ophthalmic Goods
- Sector
- APRE Health Care
- LUCY Health Care
- Exchange
- APRE Nasdaq
- LUCY Nasdaq
- Market Cap
- APRE 10.0M
- LUCY 8.9M
- IPO Year
- APRE 2019
- LUCY 2022
- Fundamental
- Price
- APRE $1.80
- LUCY $2.14
- Analyst Decision
- APRE Strong Buy
- LUCY
- Analyst Count
- APRE 2
- LUCY 0
- Target Price
- APRE $15.50
- LUCY N/A
- AVG Volume (30 Days)
- APRE 50.9K
- LUCY 5.9M
- Earning Date
- APRE 08-11-2025
- LUCY 08-11-2025
- Dividend Yield
- APRE N/A
- LUCY N/A
- EPS Growth
- APRE N/A
- LUCY N/A
- EPS
- APRE N/A
- LUCY N/A
- Revenue
- APRE $1,284,475.00
- LUCY $1,707,470.00
- Revenue This Year
- APRE N/A
- LUCY $367.48
- Revenue Next Year
- APRE N/A
- LUCY $166.67
- P/E Ratio
- APRE N/A
- LUCY N/A
- Revenue Growth
- APRE 33.27
- LUCY 22.75
- 52 Week Low
- APRE $1.41
- LUCY $1.57
- 52 Week High
- APRE $5.01
- LUCY $11.16
- Technical
- Relative Strength Index (RSI)
- APRE 49.58
- LUCY 42.95
- Support Level
- APRE $1.64
- LUCY $1.95
- Resistance Level
- APRE $1.81
- LUCY $2.20
- Average True Range (ATR)
- APRE 0.15
- LUCY 0.34
- MACD
- APRE -0.01
- LUCY -0.05
- Stochastic Oscillator
- APRE 51.76
- LUCY 5.12
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.